Inside out

Back page gossip from the 11 April issue of Research Europe

Competition overreach

An adviser to the EU’s top court has suggested that the European Commission overstepped the mark in blocking a move by the US-headquartered genomics sequencing giant Illumina to acquire Grail, a smaller US-based firm developing blood-based cancer tests.